X4 Pharmaceuticals, Inc financial data

Symbol
XFOR on Nasdaq
Location
Boston, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 17 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 574% % 27%
Debt-to-equity 151% % -43%
Return On Equity -115% % -36%
Return On Assets -46% % -99%
Operating Margin -1337% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 90,919,696 shares -48%
Common Stock, Shares, Outstanding 90,906,920 shares 1495%
Entity Public Float $14,900,000 USD -84%
Common Stock, Value, Issued $91,000 USD 1417%
Weighted Average Number of Shares Outstanding, Basic 42,292,818 shares 531%
Weighted Average Number of Shares Outstanding, Diluted 42,292,818 shares 531%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $6,500,000 USD
Revenue from Contract with Customer, Excluding Assessed Tax $35,113,000 USD 1273%
Cost of Revenue $5,757,000 USD 622%
Research and Development Expense $72,723,000 USD -11%
General and Administrative Expense $43,516,000 USD -29%
Operating Income (Loss) $86,883,000 USD -139%
Nonoperating Income (Expense) $7,725,000 USD 94%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $79,158,000 USD -113%
Income Tax Expense (Benefit) $41,000 USD -87%
Net Income (Loss) Attributable to Parent $79,199,000 USD -111%
Earnings Per Share, Basic -1.87 USD/shares 67%
Earnings Per Share, Diluted -1.87 USD/shares 67%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $217,049,000 USD 290%
Cash, Cash Equivalents, and Short-term Investments $253,000,000 USD 148%
Accounts Receivable, after Allowance for Credit Loss, Current $573,000 USD -46%
Inventory, Net $2,817,000 USD
Assets, Current $261,577,000 USD 133%
Property, Plant and Equipment, Net $182,000 USD -77%
Operating Lease, Right-of-Use Asset $1,409,000 USD -65%
Goodwill $17,351,000 USD 0%
Other Assets, Noncurrent $692,000 USD -67%
Assets $290,461,000 USD 98%
Accounts Payable, Current $5,696,000 USD -34%
Employee-related Liabilities, Current $4,303,000 USD -67%
Accrued Liabilities, Current $18,603,000 USD -19%
Contract with Customer, Liability, Current $464,000 USD
Liabilities, Current $25,757,000 USD -22%
Contract with Customer, Liability, Noncurrent $621,000 USD
Operating Lease, Liability, Noncurrent $0 USD -100%
Other Liabilities, Noncurrent $525,000 USD -37%
Liabilities $104,171,000 USD -16%
Accumulated Other Comprehensive Income (Loss), Net of Tax $109,000 USD 11%
Retained Earnings (Accumulated Deficit) $594,554,000 USD -15%
Stockholders' Equity Attributable to Parent $186,290,000 USD 741%
Liabilities and Equity $290,461,000 USD 98%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,368,000 USD 63%
Net Cash Provided by (Used in) Financing Activities $0 USD
Net Cash Provided by (Used in) Investing Activities $3,138,000 USD 41%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 90,906,920 shares 1495%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $15,434,000 USD 60%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $217,852,000 USD 286%
Deferred Tax Assets, Valuation Allowance $214,185,000 USD 16%
Deferred Tax Assets, Gross $214,584,000 USD 16%
Operating Lease, Liability $994,000 USD -63%
Depreciation $289,000 USD 366%
Lessee, Operating Lease, Liability, to be Paid $1,052,000 USD -65%
Property, Plant and Equipment, Gross $1,414,000 USD -47%
Operating Lease, Liability, Current $994,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Two $306,000 USD -77%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,052,000 USD -25%
Operating Lease, Weighted Average Discount Rate, Percent 0.115 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $58,000 USD -84%
Lessee, Operating Lease, Liability, to be Paid, Year Three $51,000 USD -82%
Deferred Tax Assets, Operating Loss Carryforwards $129,943,000 USD 13%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $200,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $45,000 USD -84%
Operating Lease, Payments $1,398,000 USD 1.5%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) $0 USD
Current Federal Tax Expense (Benefit) $0 USD
Amortization of Intangible Assets $200,000 USD
Depreciation, Depletion and Amortization $476,000 USD 668%
Deferred Tax Assets, Net of Valuation Allowance $399,000 USD -49%
Share-based Payment Arrangement, Expense $4,298,000 USD -48%
Interest Expense $8,350,000 USD 66%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%